Adoption of lecanemab, a novel infusion treatment for Alzheimer's disease (AD), has been disproportionately higher among patients who are male, white, from urban areas, and have higher socioeconomic ...

Centre for Health Services Research, 21 Claremont Place, Newcastle upon Tyne NE2 4AA, UK;martin.eccles{at}ncl.ac.uk The methods of evaluating change and improvement strategies are not well described.